Truthman speaks out here against nefarious practices by GlaxoSmithKline, the drug company. He writes about the illegal marketing of depression drug Wellbutrin as a weight-loss aid, and the tragedies caused by SSRI anti-depressants, including Prozac, Seroxat, Citalopram and Zyprexa, because of their grave side-effects. If you ever think of taking any of this pharmaceutical junk yourself, I urge you to ponder Truthman's words and the words of Dr David Healy, an expert on SSRI drugs, and think again. Improving your nutrition is far more likely to lessen depression than any pharmaceutical mind-altering drugs. Can you really trust GSK or other drug companies with the safety of your brain/mind when you read of their iniquitous behaviour? - Your brain is not infinitely elastic. Guard it from assault by psychotropic drugs.
Wednesday, November 17, 2010
Truthman speaks out against GlaxoSmithKline
Posted by
Willow
at
9:10 pm
Labels: Citalopram, David Healy, depression, GlaxoSmithKline, GSK, Prozac, psychotropic drugs, Seroxat, SSRIs, Truthman, Wellbutrin, ZYPREXA
Thursday, February 01, 2007
Pharmaceutical industry condemned by Dr David Healy, the director of psychological medicine at the University of Cardiff
Pharmaceutical industry condemned by psychologist
Extract:
"The pharmaceutical industry has been criticised by a leading psychologist for misrepresenting the efficacy of the anti depression drug Seroxat.
Patients have been "betrayed" by the misrepresentation of the drug, said Dr David Healy, the director of psychological medicine at the University of Cardiff.
His comments came in the wake of a Panorama investigation that accused GlaxoSmithKline (GSK) of hiding evidence that Seroxat had performed badly in clinical trials.
Dr Healy said: "We are in a situation now where people who are ill generally have been deeply betrayed by the whole process, deeply betrayed by the pharmaceutical companies and by all the experts that have been willing to actually lend their name to the process.""
Posted by
Willow
at
7:12 pm
Labels: Anti-depressant drug, David Healy, Pharmaceutical industry, Seroxat

